SS 04 - GYN 1: Molecular and Precision Medicine for Gynecologic Cancers in Diverse Resource Settings

Presentations

• 02:30pm - 03:45pm PT

  Discussant

  Speaker: Ann Klopp, MD, PhD - MD Anderson Cancer Center, Houston
• 02:30pm - 02:37pm PT

  Impact of MMR Status vs. Clinicopathologic Risk Factors on Locoregional Recurrence in Stage I Endometrioid Endometrial Cancer Treated with Brachytherapy Alone

  Speaker: Lara Hathout, MD, FRCPC - Rutgers Cancer Institute , New Brunswick
• 02:37pm - 02:44pm PT

  Radiation-Induced CTD-2292M14.1 Enhances Cervical Cancer Radioresistance by Promoting P62 Ubiquitination

  Speaker: Jie Zhou, PhD, RT - Sichuan Cancer Hospital and Institute, Chengdu
• 02:44pm - 02:51pm PT

  Transcriptomic Profiling Reveals Predictive Markers of Response to Concurrent Chemoradiotherapy plus Immune Checkpoint Inhibition in Cervical Cancer

  Speaker: Yuan Jie Cao, MD, PhD - Tianjin Medical University Cancer Institute and Hospital, Tian Jin
• 02:51pm - 02:58pm PT

  Tracking Changes in B Cell Antibodies in Cervical Cancer Patients Treated with Chemoradiation and Immunotherapy on GOG 9929

  Speaker: Sangwoo Kim, MD - University of California, San Diego, La Jolla
• 02:58pm - 03:05pm PT

  Hypofractionated Radiotherapy as a Potential Alternative to Conventional Treatment for Cervical Cancer in Resource-Limited Setting: A Prospective Comparative Analysis

  Speaker: Abba Mallum, MD, PhD, MBBS - Department of Radiotherapy and Oncology, Inkosi Albert Luthuli Central Hospital, Durban
• 03:05pm - 03:12pm PT

  A Real-World Comparison of Moderated Hypofractionated Radiotherapy and Conventional Fractionated Radiotherapy in Cervical Cancer

  Speaker: Zheng Zeng, MD - Peking Union Medical College Hospital, Beijing
• 03:12pm - 03:19pm PT

  Integration of Imaging and Blood-Based Biomarkers for Prognostication in Locally Advanced Cervical Cancer

  Speaker: Shrikiriti Rajan, MD - University of Iowa, Iowa City